FDA Inspection 1216256 — Amneal Pharmaceuticals Pvt. Ltd.
The FDA completed an inspection of Amneal Pharmaceuticals Pvt. Ltd. on Jul 14, 2023 in Bavla. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 14, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bavla (India)